MMBS, MMED (Path),MAACB, MACTM, MACRRM

Similar documents
Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi

THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS

Dyslipidemia. Team Members: Laila Mathkour, Khalid Aleedan, Bayan Al-Mugheerha, Fatima AlTassan

Dyslipidemia. (Med-341)

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS

Hypertriglyceridemia. Ara Metjian, M.D. Resident s Report 20 December 2002

STRUCTURE AND METABOLISM Of LIPIDS AND LIPOPROTEINS. R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty

Pathophysiology of Lipid Disorders

Antihyperlipidemic Drugs

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins

Chapter (5) Etiology of Low HDL- Cholesterol

Cholesterol metabolism. Function Biosynthesis Transport in the organism Hypercholesterolemia

Southern Derbyshire Shared Care Pathology Guidelines. Dyslipidaemia

Lipids, lipoproteins and cardiovascular disease

ANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD

Maintain Cholesterol

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry

determination of Triglyceride in Serum Amal Alamri

Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

Dyslipidaemia. Dr NM Oosthuizen Dept of Chemical Pathology SA

Lipids Types, Food Sources, Functions

Antihyperlipidemic drugs

Lipids, pt. 1. Feb. 3, Bio 28: Nutrition Instructor: Paul Nagami Laney College

Familial hypercholesterolaemia

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

Fats and Other Lipids

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC

Podcast (Video Recorded Lecture Series): Lipoprotein Metabolism and Lipid Therapy for the USMLE Step One Exam

Learning Objectives. Cholesterol and Lipids in Kids: It s a Matter of the Heart. Is Atherosclerosis a Pediatric Disease?

CLINICAL IMPORTANCE OF LIPOPROTEINS

Zuhier Awan, MD, PhD, FRCPC

Lipoproteins Metabolism

Classification. Etiology

Introduction Hyperlipidemia hyperlipoproteinemia Primary hyperlipidemia (Familial) Secondary hyperlipidemia (Acquired)

Antihyperlipidemic Drugs

Lipid/Lipoprotein Structure and Metabolism (Overview)

BIOCHEMISTRY BLOOD - SERUM Result Range Units

Lipids digestion and absorption, Biochemistry II

Lipoprotein Pathophysiology. Lipoprotein Pathophysiology

Topic 11. Coronary Artery Disease

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Lipids Board Review. Ira Goldberg, MD New York University School of Medicine. Which of the following is the best initial therapy choice?

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

Anti Hyperlipidemic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Drug regulation of serum lipids

BIOB111_CHBIO - Tutorial activity for Session 12

Chapter VIII: Dr. Sameh Sarray Hlaoui

Imbalances in lipid components

PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL

A N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides

Lipoprotein Formation, Structure and Metabolism: Cholesterol Balance and the Regulation of Plasma Lipid Levels

Lipid & Fat: Overview

Management of Post-transplant hyperlipidemia

DYSLIPIDEMIA PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Joslin Diabetes Center Advances in Diabetes and Thyroid Disease 2013 Consensus and Controversy in Diabetic Dyslipidemia

Cholesterol, Heart Attack and Stroke. Dr Tai E Shyong Consultant Department of Endocrinology Singapore General Hospital

MOLINA HEALTHCARE OF CALIFORNIA

Nutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source

OM s Health Corner Cholesterol & Heart Disease!!

Focus on FH (Familial Hypercholesterolemia) Joshua W. Knowles, MD PhD for PCNA May, 2013

Advances in Lipid Management

An educational booklet for patients with familial hypercholesterolemia DR. LEIV OSE

Walter B. Bayubay CLS (ASCP), AMT, MA Ed, CPI

CHOLESTEROL CONTENT CREATED BY. Learn more at

Case Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic

BCH 447. Triglyceride Determination in Serum

ATP IV: Predicting Guideline Updates


Nutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source

History. Aron first proposed that fat may be essential for normal growth Tested on animals-vitamins A,D,E added. Fat deficiency severely affected

Lipids do not like water! (aka: hydrophobic) Generally insoluble

Lipid & Fat: Overview

STATIN UTILIZATION MANAGEMENT CRITERIA

Pediatric Dyslipidemia: Angela Gooden MSN, RN, CPNP- AC/PC, Texas Children s Hospital, Pediatric Cardiology

Death is inevitable but premature death is not. Sir Richard Doll

Cholesterol Levels -- What They Mean, Diet and Treatment

Your cholesterol levels. Questions or concerns

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

A Review: Atherosclerosis & its treatment

B. Patient has not reached the percentage reduction goal with statin therapy

Lipid Metabolism in Familial Hypercholesterolemia

10/1/2008. Therapy? Disclosure Statement

Lipid Management: A Case-Based Approach. Overview. Simple Lipid Therapy Approach. Patients have lipid disorders of:

Lipid Metabolism Prof. Dr. rer physiol. Dr.h.c. Ulrike Beisiegel

LIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI

Lipids. PBHL 211 Darine Hachem, MS, LD

Financial Disclosures

North Americans consume 100 g of fat per day on

CHAPTER 28 LIPIDS SOLUTIONS TO REVIEW QUESTIONS

Definition: Water insoluble No common structure (though generally large R groups)

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Approach to Dyslipidemia among diabetic patients

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

High density lipoprotein metabolism

Management of dyslipidaemia in HIV infected children: rationale for treatment algorithm

Familial Hypercholesterolemia

Metabolism, Atherogenic Properties and Agents to reduce Triglyceride-Rich Lipoproteins Manfredi Rizzo, MD, PhD

Lipids What s new (and what s not)

Transcription:

Dr Mere Kende MMBS, MMED (Path),MAACB, MACTM, MACRRM Lecturer- SMSH

Brief Overview of Lipids What is dyslipidemia? Classification of hyperlipidemia Primary vs secondary hyperlipidemia Hypercholesterolaemia & Hypertriglyceridemia Diagnosis & Treatment 5mins Video References

Constituents of living cells Primary source of energy, precursors for steroid, hormones PGs,& leukotrienes Important structural components of cell membranes Components of bile for digestion

Fatty Acids Triacylglycerols (TRIGLYCERIDES) Cholesterols (sterols) Sterol esters Phospholipids Bile acids

FAT

Mader. Human Biology, 7 th Edition

Hydrophobic End Hydrophilic End

Relative insolubility in water Most lipids except Phospholipids are hydrophobic Has to be packaged as lipoproteins in specific protein complexes (apo-proteins) for transport in plasma FFA (>18Carbon) is transported in albumin

Mader. Human Biology, 7 th Edition

Mader. Human Biology, 7 th Edition

Mader. Human Biology, 7 th Edition

Mader. Human Biology, 7 th Edition

Are apo-protein + packaged lipids Make lipids water soluble for transport in plasma Carry varying amounts of fat to different tissues Apo-proteins are enzyme co-factors, structural proteins & ligands for receptor recognition

Chylomicrons (Diet TRIG) VLDL (Liver TRIG) LDL (Liver) IDL (Tissues form VLDL) HDL (liver) Chylomicron remnants (Tissue from chylomicrons) Lipoprotein (a)

Harrison s Principle of Internal Medicine 17 th Ed

Harper s illustrated Biochemistry 26 th Ed, 2003

Triglycerides (triacyl glcerol) Free Cholesterol & Cholesteryl esters Phospholipids FFA (small)

A. Despopoulous, S. Silbenagl. Colour Atlas of Physiology, 5 th Edition

Chylomicrons (TRIG)- apob48- supplied in DIET VLDL (TRIG)-ApoB100,E,C synthesis : Liver + GIT LDL derived from VLDL in liver, Apo B100 transport CHO to peripheral tissues HDLC Apo A,E & C transport CHO to liver for excretion

Harper s Ilustrated Biochemistry 26 th Ed, 2003

Refers to abnormal metabolism of lipoproteins/lipids Hypolipoproteinemia Hyperlipidemia Tangier s Disease

Refers to high cholesterol or high triglycerides Primary/Genetic/Familial Causes Secondary: Diabetes, hypothyroid, nephrotic syndrome Obesity Oral contraceptives steroids Combined cause/polygenic

Acute Coronary Syndrome Stroke Peripheral Vessel Disease (claudication)

Atlas of clinical Diagnosis, 2 nd Edition

ABC of Dermatology, BMJ Pub, 4 th Edition Atlas of clinical Diagnosis, 2 nd Edition

Cardiovascular Risk Assessment TOO MANY -------- NOT GOOD Overweight Diabetes Over-weight Diabetes Hypertension Cholesterol HIGHEST RISK Smoking NORMAL RISK

Isolated high cholesterol (CHO) Isolated high triglycerides (TRIG) Combined elevation of both CHO & TRIG

Inherited Due to various defects in catabolism of lipoprotein include defective transport proteins (apo-proteins), receptors and ligands for receptors (apo E) Early onset of CVD/stroke (<40y old) Acute pancreatitis (+ very high TRIG) Xanthomas (skin, tendons, extensor surfaces, eyelids) Family members with hyperlipidemia/early CVD deaths

Type I------V Based on type of lipoprotein elevated Results in elevation of cholesterol or triglycerides or both

Familial hyperlipoproteinemia

Autosomal dominant Defect in LDL receptors/apo B100 Isolated high CHO- almost due to raised LDL Normal TG CVD Risk 25x >normal after 30 Family history of early death/cvd, Heterozygous >9mmol/L; symptoms at 30-40y; CVD at 50/60y Homozygous >15mmol/L; early CVD; die before 20y

Tendon xanthomas (most commonly of the Achilles tendons and the extensor tendons of the knuckles), tuberous xanthomas (softer,painless nodules on the ankles and buttocks), & xanthelasmas (deposits on the eyelids) are common.

Yellow, creamy & elevated papule

Large subcutaneous tumor adherent to the Achilles Tendon.

Phenotype I (AR) IIa (AD) IIb LP high chylo LDL LDL & VLDL III (AD) Chylo remnants & IDL IV (AD) VLDL V (AR) Chylo & VLDL TRIG >9++ <3 3-9 3-9 3-9 >9++ CHO <6 >7-13 6-13 6-13 -/+ 6-13 Plasma milky clear clear turbid turbid milky xanthomas Eruptive, buttocks Knee/ elbow none Palmar, tendon none pancreatitis yes no no no no yes IHD no Yes ++ Yes++ Yes++ -/+ -+ PVD no yes yes yes -/+ -/+ Gene defect LPL, apocii LDL R/ B100? Apo E2/E2 Apo A- V? yes Apo A- V?

Diabetes Mellitus (high TRIG+/- CHO) Nephrotic syndrome (high CHO) Severe Hypothyroidism (high CHO) Cushing s Syndrome (TRIG) Obesity (TRIG) OCP (TRIG) Cholestasis/Obstructive Jaundice (high CHO)

High CHO and LDLC No identifiable mode of inheritance?environmental & poorly understood genetics Diet alone can control CHO in some patients

Total cholesterol LDL cholesterol (LDLC) HDL cholesterol (HDL) Ratio of LDL:HDLC Triglycerides Apo-lipoproteins A & B Lipoprotein (a)

Measured after an overnight fast. Creamy layer in tube non-fasting/defect in chylomicron metabolism Plasma is usually clear when TG levels are <4.5 mmol/l (<400 mg/dl) & cloudy when levels are higher

Clinical- early CVD, very high CHO, xanthomas Many diagnosed incidentally Laboratory Total cholesterol Triglycerides LDLC & HDLC Ratio LDLC:HDLC Others: Small dense LDLC Apo A and B Lipoprotein (a) & lipoprotein electrophoresis

Normal TRIG level > 2.3 mmol/l (> 200 mg/dl). Normal Total cholesterol <5.5mmol/L HDL Cholesterol Good cholesterol <1mmol/L ---Bad LDLC Bad cholesterol >2.5mmol/L Bad

Over-weight /Obesity Hypertension Diabetes Mellitus Heart Disease

Lifestyle changes (Weight Loss /diet/exercise) Medication Lower Cholesterol & Triglycerides Treat secondary problems

Lifestyle Changes (smoking/alcohol/drug) Weight loss BMI= wt (kg)/ht x ht (m) IBW= [ 25 x ht x ht] (m) Acceptable IBW= IBW + 10% of IBW Low fat Diet Exercise (3omins /day) Manage existing Risk factors (DM)

Fish, canola oil & flaxseeds (Omega 3) Olive oil Nuts (unsaturated Fatty Acids) Peanuts, walnuts, almonds, hazelnuts High Fibre (oat meal, oat bran, kidney beans, apples, pears) Green Leafy Vegetables

Adapted from Lullman Color Atlas of Pharmacology 2000

HMG co-enzyme reductase (statins)-block Cholesterol synthesis) Simvastatin, pravastatin, atorvastatains, lovastains Cholesterol absorption inhibitors (enhances excretion) ezitimibe Bile acid sequestrant (Increase LDLC excretion) Cholestyramine, cholestipol & cholesvelem Nicotinic acid (increases LDLC & TRIG excretion) Clofibrates (Increase LDLC excretion & Increase HDLC) Gemfibrozil & fenofibrozil Fish Oil (Omega 3)---decreases TRIG

What Does Diabetes Do.mp4

ESC Koay & N Walmsley: A primer of Chemical Pathology 1996 Harrisons Principle of Internal Medicine 17 th Edition PJ. Gallagher, GA Tanner. Medical Physiology, 2 nd edition A. Despopoulous, S. Silbenagl. Colour Atlas of Physiology, 5 th Edition